Johnson & Johnson vs Paycom Software Inc — how do they compare? Johnson & Johnson trades at $261.68 (market cap $628.65B), while Paycom Software Inc trades at $212.99 (market cap $9.52B). The key difference: Johnson & Johnson is far larger — about 66× Paycom Software Inc's market cap, and Johnson & Johnson pays the higher dividend (2.05%). Which is the better fit depends on your goals.
| JNJ | PAYC | |
|---|---|---|
Market Cap | $628.65B | $9.52B |
Volume | 6,156,228 | — |
Sector | Health | Technology |
52-Week High | $267.24 | $233.89 |
52-Week Low | $174.16 | $113.59 |
Enterprise Value | $656.92B | $10.31B |
Dividend Yield | 2.05% | 0.71% |
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $260.88, down 0.36% today, with a bullish technical signal supported by moving averages. The stock shows strong profitability with a net margin of 21.48% and ROE of 25.74%, though valuations like a P/E of 30.14 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and the company maintains a 64-year dividend growth streak, with analyst consensus leaning bullish.
Outlook remains positive with a consensus price target of $284.50, offering potential upside, but risks include legal challenges and high debt-to-asset ratio of 24.06% in 2025. Investors benefit from steady dividends and defensive positioning in healthcare, though valuation multiples may limit near-term gains amid economic uncertainty.
Paycom Software (PAYC) trades at $211.28, down 1.02% today, with a bullish technical outlook per moving averages but overbought RSI signals. The company reported strong Q2 2026 results, beating EPS estimates with $2.78 versus $2.38 expected, and raised its full-year revenue and EBITDA guidance, driven by AI-driven demand and operational efficiency.
The stock offers growth potential from robust earnings momentum and high profitability margins, but risks include valuation premiums and competitive pressures. Analyst consensus is mixed with a $219.22 price target, suggesting moderate upside from current levels amid near-term volatility.
Trailing returns across standard periods
Latest headlines on both assets
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →Paycom is a fast-growing provider of payroll and human capital management, or HCM, software primarily targeting clients with 50-10,000 employees in the United States. Paycom was established in 1998 and services about 18,000 clients as of 2021, based on parent company grouping. Alongside its core payroll software, Paycom offers various HCM add-on modules, including time and attendance, talent management, and benefits administration.
Read more on PAYC →